Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Portola Sued by Investor Readying Challenge to Alexion Deal

July 1, 2020, 7:29 PM

Portola Pharmaceuticals Inc. faces a suit in Delaware by an investor seeking to probe suspicions that its board is relying on the coronavirus to force through an underpriced $1.4 billion buyout by Alexion Pharmaceuticals Inc.

“The sale of Portola to Alexion appears to be the product” of “pandemic-driven fear” that “contradicts the confidence Portola management demonstrated in the company’s long-term prospects,” the Chancery Court complaint filed Wednesday says.

The suit accuses Portola’s board of panicking and rushing into the merger after the collapse of talks over a potential European Union license for its top drug, Andexxa, which is used to ...